CytoCore Signs Agreement to Sell Synermed’s General Cytology Preservative

CytoCore, Inc., the developer of cost-effective products used for the detection of cancerous and precancerous conditions and privately held Synermed Select Partners … announced a distribution agreement that gives CytoCore US and international rights to distribute the Synermed General Cytology Preservative in combination with its SoftPAP cervical cell collection device.
TradingMarkets